Yang Yonghua, Rao Rehka, Shen Jie, Tang Yun, Fiskus Warren, Nechtman John, Atadja Peter, Bhalla Kapil
Medical College of Georgia Cancer Center, Augusta, Georgia, USA.
Cancer Res. 2008 Jun 15;68(12):4833-42. doi: 10.1158/0008-5472.CAN-08-0644.
Heat shock protein (hsp) 90 is an ATP-dependent molecular chaperone that maintains the active conformation of client oncoproteins in cancer cells. An isoform, hsp90alpha, promotes extracellular maturation of matrix metalloproteinase (MMP)-2, involved in tumor invasion and metastasis. Knockdown of histone deacetylase (HDAC) 6, which deacetylates lysine residues in hsp90, induces reversible hyperacetylation and attenuates ATP binding and chaperone function of hsp90. Here, using mass spectrometry, we identified seven lysine residues in hsp90alpha that are hyperacetylated after treatment of eukaryotic cells with a pan-HDAC inhibitor that also inhibits HDAC6. Depending on the specific lysine residue in the middle domain involved, although acetylation affects ATP, cochaperone, and client protein binding to hsp90alpha, acetylation of all seven lysines increased the binding of hsp90alpha to 17-allyl-amino-demethoxy geldanamycin. Notably, after treatment with the pan-HDAC inhibitor panobinostat (LBH589), the extracellular hsp90alpha was hyperacetylated and it bound to MMP-2, which was associated with increased in vitro tumor cell invasiveness. Treatment with antiacetylated hsp90alpha antibody inhibited in vitro invasion by tumor cells. Thus, reversible hyperacetylation modulates the intracellular and extracellular chaperone function of hsp90, and targeting extracellular hyperacetylated hsp90alpha may undermine tumor invasion and metastasis.
热休克蛋白(hsp)90是一种依赖ATP的分子伴侣,可维持癌细胞中客户癌蛋白的活性构象。一种异构体hsp90α可促进基质金属蛋白酶(MMP)-2的细胞外成熟,MMP-2参与肿瘤侵袭和转移。组蛋白脱乙酰酶(HDAC)6可使hsp90中的赖氨酸残基去乙酰化,敲低HDAC6可诱导hsp90发生可逆的超乙酰化,并减弱其ATP结合和分子伴侣功能。在此,我们使用质谱法鉴定出hsp90α中的7个赖氨酸残基,在用一种也抑制HDAC6的泛HDAC抑制剂处理真核细胞后,这些残基会发生超乙酰化。根据中间结构域中具体涉及的赖氨酸残基不同,尽管乙酰化会影响ATP、共分子伴侣以及客户蛋白与hsp90α的结合,但所有7个赖氨酸的乙酰化均增加了hsp90α与17-烯丙基氨基-去甲氧基格尔德霉素的结合。值得注意的是,在用泛HDAC抑制剂帕比司他(LBH589)处理后,细胞外的hsp90α发生超乙酰化,并与MMP-2结合,这与体外肿瘤细胞侵袭性增加相关。用抗乙酰化hsp90α抗体处理可抑制肿瘤细胞的体外侵袭。因此,可逆的超乙酰化调节hsp90的细胞内和细胞外分子伴侣功能,靶向细胞外超乙酰化的hsp90α可能会破坏肿瘤侵袭和转移。